COOK DAVID N 4
4 · Seres Therapeutics, Inc. · Filed Jan 30, 2018
Insider Transaction Report
Form 4
COOK DAVID N
See Remarks
Transactions
- Exercise/Conversion
RESTRICTED STOCK UNITS
2018-01-26−5,000→ 20,000 total→ COMMON STOCK (5,000 underlying) - Sale
COMMON STOCK
2018-01-26$11.02/sh−1,738$19,153→ 139,935 total - Award
STOCK OPTION (RIGHT TO BUY)
2018-01-30−75,000→ 75,000 totalExercise: $10.42Exp: 2028-01-29→ COMMON STOCK (75,000 underlying) - Exercise/Conversion
COMMON STOCK
2018-01-26+5,000→ 141,673 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020.
- [F3]The Option will vest as to 25% of the shares on January 30, 2019. The remainder of the shares will vest in 12 equal quarterly installments thereafter.